A novel polyethyleneimine-coated adeno-associated virus-like particle formulation for efficient siRNA delivery in breast cancer therapy: preparation and in vitro analysis

Wei Shao1, Arghya Paul1, Sana Abbasi1, Parminder S Chahal2, Jimmy A Mena2, Johnny Montes2, Amine Kamen2, Satya Prakash11Biomedical Technology and Cell Therapy Research Laboratory, Department of Biomedical Engineering and Artificial Cells and Organs Research Centre, Faculty of Medicine, McGill Univer...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shao W, Paul A, Abbasi S, Chahal PS, Mena JA, Montes J, Kamen A, Prakash S
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://doaj.org/article/94c33167a3464d6db0a59a278be8f3a1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:94c33167a3464d6db0a59a278be8f3a1
record_format dspace
spelling oai:doaj.org-article:94c33167a3464d6db0a59a278be8f3a12021-12-02T02:39:49ZA novel polyethyleneimine-coated adeno-associated virus-like particle formulation for efficient siRNA delivery in breast cancer therapy: preparation and in vitro analysis1176-91141178-2013https://doaj.org/article/94c33167a3464d6db0a59a278be8f3a12012-03-01T00:00:00Zhttp://www.dovepress.com/a-novel-polyethyleneimine-coated-adeno-associated-virus-like-particle--a9561https://doaj.org/toc/1176-9114https://doaj.org/toc/1178-2013Wei Shao1, Arghya Paul1, Sana Abbasi1, Parminder S Chahal2, Jimmy A Mena2, Johnny Montes2, Amine Kamen2, Satya Prakash11Biomedical Technology and Cell Therapy Research Laboratory, Department of Biomedical Engineering and Artificial Cells and Organs Research Centre, Faculty of Medicine, McGill University, 2Animal Cell Technology, Bioprocess Centre, Biotechnology Research Institute, National Research Council, Montreal, Quebec, CanadaBackground: Systemic delivery of small interfering RNA (siRNA) is limited by its poor stability and limited cell-penetrating properties. To overcome these limitations, we designed an efficient siRNA delivery system using polyethyleneimine-coated virus-like particles derived from adeno-associated virus type 2 (PEI-AAV2-VLPs).Methods: AAV2-VLPs were produced in insect cells by infection with a baculovirus vector containing three AAV2 capsid genes. Using this method, we generated well dispersed AAV2-VLPs with an average diameter of 20 nm, similar to that of the wild-type AAV2 capsid. The nanoparticles were subsequently purified by chromatography and three viral capsid proteins were confirmed by Western blot. The negatively charged AAV2-VLPs were surface-coated with PEI to develop cationic nanoparticles, and the formulation was used for efficient siRNA delivery under optimized transfection conditions.Results: PEI-AAV2-VLPs were able to condense siRNA and to protect it from degradation by nucleases, as confirmed by gel electrophoresis. siRNA delivery mediated by PEI-AAV2-VLPs resulted in a high transfection rate in MCF-7 breast cancer cells with no significant cytotoxicity. A cell death assay also confirmed the efficacy and functionality of this novel siRNA formulation towards MCF-7 cancer cells, in which more than 60% of cell death was induced within 72 hours of transfection.Conclusion: The present study explores the potential of virus-like particles as a new approach for gene delivery and confirms its potential for breast cancer therapy.Keywords: adeno-associated virus type 2, virus-like particles, small interfering RNA delivery, breast cancer therapy, nanomedicineShao WPaul AAbbasi SChahal PSMena JAMontes JKamen APrakash SDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2012, Iss default, Pp 1575-1586 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Shao W
Paul A
Abbasi S
Chahal PS
Mena JA
Montes J
Kamen A
Prakash S
A novel polyethyleneimine-coated adeno-associated virus-like particle formulation for efficient siRNA delivery in breast cancer therapy: preparation and in vitro analysis
description Wei Shao1, Arghya Paul1, Sana Abbasi1, Parminder S Chahal2, Jimmy A Mena2, Johnny Montes2, Amine Kamen2, Satya Prakash11Biomedical Technology and Cell Therapy Research Laboratory, Department of Biomedical Engineering and Artificial Cells and Organs Research Centre, Faculty of Medicine, McGill University, 2Animal Cell Technology, Bioprocess Centre, Biotechnology Research Institute, National Research Council, Montreal, Quebec, CanadaBackground: Systemic delivery of small interfering RNA (siRNA) is limited by its poor stability and limited cell-penetrating properties. To overcome these limitations, we designed an efficient siRNA delivery system using polyethyleneimine-coated virus-like particles derived from adeno-associated virus type 2 (PEI-AAV2-VLPs).Methods: AAV2-VLPs were produced in insect cells by infection with a baculovirus vector containing three AAV2 capsid genes. Using this method, we generated well dispersed AAV2-VLPs with an average diameter of 20 nm, similar to that of the wild-type AAV2 capsid. The nanoparticles were subsequently purified by chromatography and three viral capsid proteins were confirmed by Western blot. The negatively charged AAV2-VLPs were surface-coated with PEI to develop cationic nanoparticles, and the formulation was used for efficient siRNA delivery under optimized transfection conditions.Results: PEI-AAV2-VLPs were able to condense siRNA and to protect it from degradation by nucleases, as confirmed by gel electrophoresis. siRNA delivery mediated by PEI-AAV2-VLPs resulted in a high transfection rate in MCF-7 breast cancer cells with no significant cytotoxicity. A cell death assay also confirmed the efficacy and functionality of this novel siRNA formulation towards MCF-7 cancer cells, in which more than 60% of cell death was induced within 72 hours of transfection.Conclusion: The present study explores the potential of virus-like particles as a new approach for gene delivery and confirms its potential for breast cancer therapy.Keywords: adeno-associated virus type 2, virus-like particles, small interfering RNA delivery, breast cancer therapy, nanomedicine
format article
author Shao W
Paul A
Abbasi S
Chahal PS
Mena JA
Montes J
Kamen A
Prakash S
author_facet Shao W
Paul A
Abbasi S
Chahal PS
Mena JA
Montes J
Kamen A
Prakash S
author_sort Shao W
title A novel polyethyleneimine-coated adeno-associated virus-like particle formulation for efficient siRNA delivery in breast cancer therapy: preparation and in vitro analysis
title_short A novel polyethyleneimine-coated adeno-associated virus-like particle formulation for efficient siRNA delivery in breast cancer therapy: preparation and in vitro analysis
title_full A novel polyethyleneimine-coated adeno-associated virus-like particle formulation for efficient siRNA delivery in breast cancer therapy: preparation and in vitro analysis
title_fullStr A novel polyethyleneimine-coated adeno-associated virus-like particle formulation for efficient siRNA delivery in breast cancer therapy: preparation and in vitro analysis
title_full_unstemmed A novel polyethyleneimine-coated adeno-associated virus-like particle formulation for efficient siRNA delivery in breast cancer therapy: preparation and in vitro analysis
title_sort novel polyethyleneimine-coated adeno-associated virus-like particle formulation for efficient sirna delivery in breast cancer therapy: preparation and in vitro analysis
publisher Dove Medical Press
publishDate 2012
url https://doaj.org/article/94c33167a3464d6db0a59a278be8f3a1
work_keys_str_mv AT shaow anovelpolyethyleneiminecoatedadenoassociatedviruslikeparticleformulationforefficientsirnadeliveryinbreastcancertherapypreparationandinvitroanalysis
AT paula anovelpolyethyleneiminecoatedadenoassociatedviruslikeparticleformulationforefficientsirnadeliveryinbreastcancertherapypreparationandinvitroanalysis
AT abbasis anovelpolyethyleneiminecoatedadenoassociatedviruslikeparticleformulationforefficientsirnadeliveryinbreastcancertherapypreparationandinvitroanalysis
AT chahalps anovelpolyethyleneiminecoatedadenoassociatedviruslikeparticleformulationforefficientsirnadeliveryinbreastcancertherapypreparationandinvitroanalysis
AT menaja anovelpolyethyleneiminecoatedadenoassociatedviruslikeparticleformulationforefficientsirnadeliveryinbreastcancertherapypreparationandinvitroanalysis
AT montesj anovelpolyethyleneiminecoatedadenoassociatedviruslikeparticleformulationforefficientsirnadeliveryinbreastcancertherapypreparationandinvitroanalysis
AT kamena anovelpolyethyleneiminecoatedadenoassociatedviruslikeparticleformulationforefficientsirnadeliveryinbreastcancertherapypreparationandinvitroanalysis
AT prakashs anovelpolyethyleneiminecoatedadenoassociatedviruslikeparticleformulationforefficientsirnadeliveryinbreastcancertherapypreparationandinvitroanalysis
AT shaow novelpolyethyleneiminecoatedadenoassociatedviruslikeparticleformulationforefficientsirnadeliveryinbreastcancertherapypreparationandinvitroanalysis
AT paula novelpolyethyleneiminecoatedadenoassociatedviruslikeparticleformulationforefficientsirnadeliveryinbreastcancertherapypreparationandinvitroanalysis
AT abbasis novelpolyethyleneiminecoatedadenoassociatedviruslikeparticleformulationforefficientsirnadeliveryinbreastcancertherapypreparationandinvitroanalysis
AT chahalps novelpolyethyleneiminecoatedadenoassociatedviruslikeparticleformulationforefficientsirnadeliveryinbreastcancertherapypreparationandinvitroanalysis
AT menaja novelpolyethyleneiminecoatedadenoassociatedviruslikeparticleformulationforefficientsirnadeliveryinbreastcancertherapypreparationandinvitroanalysis
AT montesj novelpolyethyleneiminecoatedadenoassociatedviruslikeparticleformulationforefficientsirnadeliveryinbreastcancertherapypreparationandinvitroanalysis
AT kamena novelpolyethyleneiminecoatedadenoassociatedviruslikeparticleformulationforefficientsirnadeliveryinbreastcancertherapypreparationandinvitroanalysis
AT prakashs novelpolyethyleneiminecoatedadenoassociatedviruslikeparticleformulationforefficientsirnadeliveryinbreastcancertherapypreparationandinvitroanalysis
_version_ 1718402304553517056